16 Hrs
Source:
USA TODAY
Source: USA TODAY
16 HrsUSA TODAY
Source: USA TODAY
16 HrsReady to play
Ready to play
Starbucks has ended insurance coverage for obesity medications such as Wegovy and Zepbound, leaving employee Noah Stevens unable to afford her $350 monthly Wegovy cost. KFF data show that the share of large employers covering GLP-1 drugs for obesity fell from 43% to 33% between the survey’s previous year and 2026, with companies citing rising costs. Some employers are directing workers to drugmakers’ direct-sales services or weight-loss vendors, where some medications are available at lower monthly prices.
Notice: This Is an AI-Generated Summary
Comments (0)